Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MF
A promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund acquiring the stake. The transaction comes amid strong earnings growth, healthy margins and sustained momentum in the company’s pharmaceutical business.

Kotak AMC’s Shibani Sircar Kurian bets on financials and healthcare; cautious on IT
Shibani Sircar Kurian, Head -Equity Research and Fund Manager at Kotak Mahindra AMC, which manages assets worth nearly $4.79 billion, said the ongoing Middle East conflict remains the biggest concern for Indian markets due to its potential impact on oil prices, growth and earnings. She said Kotak AMC remains selective, favouring financials, healthcare and parts of industrials, while staying cautious on smallcaps and Indian IT amid AI-led disruption. Disclaimer: The views and investment tips expressed by investment experts on CNBCTV18.com are their own and not that of the website or its management. CNBCTV18.com advises users to check with certified experts before taking any investment decisions.
Unique Picks: 6 stocks held by only one MF scheme in April, falling up to 40% in CY26
An analysis of mutual fund portfolios revealed 29 stocks held exclusively by single schemes, with most underperforming in CY26. However, Satin Creditcare Network, Rossell Techsys, and Amanta Healthcare bucked the trend, delivering strong returns. Brooks Laboratories and EFC (I) were among those experiencing significant declines.

Nippon India Mutual Fund raises stake in this healthcare stock. Do you own? - Mint
Nippon India Mutual Fund raises stake in this healthcare stock. Do you own?Mint

Q4 Results LIVE Updates: DMart shares down 4%, ideaForge Technologies up 16%; Ambuja report today
Q4 Results LIVE Updates: Amubja Cements, Manappuram Finance, Godrej Properties, Aditya Birla Capital, Tata Technologies, KEI Industries, Jindal Stainless, BHEL, Aarti Industries, Sobha, Quess Corp, Tata Chemicals, Wockhardt, are among the companies reporting their earnings today. Also watch for earnings reactions from Avenue Supermarts, Kotak Mahindra Bank, CDSL, NSDL, Zen Technologies, Mazagon Dock and others. Watch this space for all the LIVE earnings reactions.

Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — 4 May 2026
Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — Reliance, Kotak Mahindra Bank, and Sun Pharma
Where to invest now: SBI MF prefers large caps, pharma, PSU banks
Ruchit Mehta, Head of Research at SBI Mutual Fund, prefers CDMO and hospital plays within pharma, citing stronger growth prospects over generics. He sees large caps as attractive on valuations, while midcaps require selectivity amid earnings risks. PSU banks may outperform in the near term due to stronger loan growth, but asset quality risks could emerge over the next 2–3 quarters if global disruptions persist.
Nippon India Mutual Fund Increases Stake in Syngene International to 7.12% - scanx.trade
Nippon India Mutual Fund Increases Stake in Syngene International to 7.12%scanx.trade
MF Favourites take a hit: 14 smallcap stocks slide up to 50% in 3 months
Despite rising mutual fund stakes, several smallcap stocks have plunged up to 47% in 2026, highlighting market uncertainty and raising questions on whether these beaten-down picks offer value or further downside.
Sensex Today Trades Lower | Nifty Below 22,700 | Kotak Mahindra & Sun Pharma Top Losers - Equitymaster
Sensex Today Trades Lower | Nifty Below 22,700 | Kotak Mahindra & Sun Pharma Top LosersEquitymaster

Kotak Mahindra Mutual Fund acquires stake in this recently listed healthcare stock
Kotak Mahindra Mutual Fund (KMMF) has raised its stake in the North Indian hospital network Park Medi World Limited to more than 5%. The fund purchased 175,164 shares, bringing its total ownership to 5.0393%, which necessitates a regulatory announcement in accordance with SAST regulations.

PE Firm True North Sells 3.6% Stake In Anthem Biosciences For Rs 1,261 Crore
HDFC Mutual Fund (MF) and SBI MF have collectively acquired 93,01,020 shares or 1.65% holding in Anthem Biosciences at an average price of Rs 621.10 apiece.